Replimune Group
REPL
150 hedge funds and large institutions have $548M invested in Replimune Group in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 19 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 36
53% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 19
7% more funds holding
Funds holding: 140 → 150 (+10)
8% less capital invested
Capital invested by funds: $594M → $548M (-$46.5M)
10.13% less ownership
Funds ownership: 119.34% → 109.21% (-10%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $837K | Put options by funds: $1.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$14.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$11.3M |
| 3 |
JFG
Jefferies Financial Group
New York
|
+$8.2M |
| 4 |
D.E. Shaw & Co
New York
|
+$6.19M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$51.2M |
| 2 |
Goldman Sachs
New York
|
-$14.2M |
| 3 |
DM
Deerfield Management
New York
|
-$8.27M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.42M |
| 5 |
AG
Artal Group
Luxembourg
|
-$4.21M |
REPL Hedge Fund Activity: Q1 2024 in Review
150 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q1 2024, worth a combined $548M — down 7.8% from $594M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new REPL positions and 19 closed out — a net gain of 10 holders — while 58 added to existing stakes and 36 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $14.4M. The largest seller was Morgan Stanley, cutting an estimated $51.2M.
- 150 institutional investors held Replimune Group (REPL) as of Q1 2024, up from 140 in Q4 2023.
- Funds reported $548M of Replimune Group stock for Q1 2024, down 7.8% quarter-over-quarter.
- 29 funds opened new Replimune Group positions in Q1 2024 and 19 closed out, a net change of +10 holders.
- The largest Replimune Group buyer in Q1 2024 was Camber Capital Management, an estimated $14.4M added.
- The largest Replimune Group seller in Q1 2024 was Morgan Stanley, an estimated $51.2M sold.
Based on aggregated 13F filings for Q1 2024.